SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves

被引:1
作者
de Visscher, Nathalie [1 ]
Holemans, Xavier [1 ]
Gillain, Aline [2 ]
Kornreich, Anne [3 ]
Lagasse, Raphael [4 ,5 ,6 ]
Piette, Philippe [4 ]
Ventura, Manfredi [7 ]
Thys, Frederic [2 ,8 ,9 ,10 ]
机构
[1] Grand Hop Charleroi GHdC, Dept Infectiol & Internal Med, B-6000 Charleroi, Belgium
[2] Grand Hop Charleroi GHdC, Clin Res & Translat Unit, B-6000 Charleroi, Belgium
[3] Grand Hop Charleroi GHdC, Dept Lab Med, B-6000 Charleroi, Belgium
[4] Grand Hop Charleroi GHdC, Dept Med Econ Informat, B-6000 Charleroi, Belgium
[5] Grand Hop Charleroi GHdC, Dept Informat Technol, B-6000 Charleroi, Belgium
[6] Univ Libre Bruxelles ULB, Sch Publ Hlth, B-1070 Brussels, Belgium
[7] Grand Hop Charleroi GHdC, Dept Med Management Team, B-6000 Charleroi, Belgium
[8] Grand Hop Charleroi GHdC, Dept Acute & Emergency Med, B-6000 Charleroi, Belgium
[9] Catholic Univ Louvain, Continuing Educ Unit UCLouvain Woluwe, B-1200 Woluwe St Lambert, Belgium
[10] Univ Catholic Lille, CEM ETHICS EA 7446, F-59000 Lille, France
来源
VIRUSES-BASEL | 2022年 / 14卷 / 07期
关键词
healthcare workers; SARS-CoV-2; seroprevalence; pandemic waves; Belgium; COVID-19;
D O I
10.3390/v14071535
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Grand Hopital de Charleroi is a large non-academic Belgian hospital that treated a large number of COVID-19 inpatients. In the context of this pandemic, all professions-combined healthcare workers (HCWs), and not only direct caregivers, are a frontline workforce in contact with suspected and confirmed COVID-19 cases and seem to be a high-risk group for exposure. The aim of our study was to estimate the prevalence of anti-SARS-CoV-2 antibodies in HCWs in our hospital after the first and second pandemic waves and to characterize the distribution of this seroprevalence in relation to various criteria. Methods: At the end of the two recruitment periods, a total of 4008 serological tests were performed in this single-center cross-sectional study. After completing a questionnaire including demographic and personal data, possible previous COVID-19 diagnostic test results and/or the presence of symptoms potentially related to COVID-19, the study participants underwent blood sampling and serological testing using DiaSorin's LIAISON (R) SARS-CoV-2 S1/S2 IgG test for the first phase and LIAISON (R) SARS-CoV-2 TrimericS IgG test for the second phase of this study. Results: In total, 302 study participants (10.72%) in the first round of the study and 404 (33.92%) in the second round were positive for SARS-CoV-2-IgG antibodies. The prevalence of seropositivity observed after the second wave was 3.16 times higher than after the first wave. We confirmed that direct, prolonged, and repeated contact with patients or their environment was a predominant seroconversion factor, but more unexpectedly, that this was the case for all HCWs and not only caregivers. Finally, the notion of high-risk contact seemed more readily identifiable in one's workplace than in one's private life. Conclusions: Our study confirmed that HCWs are at a significantly higher risk of contracting COVID-19 than the general population, and suggests that repeated contacts with at-risk patients, regardless of the HCWs' professions, represents the most important risk factor for seroconversion.
引用
收藏
页数:11
相关论文
共 33 条
[1]  
[Anonymous], COVID 19 B EPIDEMIOL
[2]   Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals [J].
Behrens, Georg M. N. ;
Cossmann, Anne ;
Stankov, Metodi V. ;
Witte, Torsten ;
Ernst, Diana ;
Happle, Christine ;
Jablonka, Alexandra .
INFECTION, 2020, 48 (04) :631-634
[3]   Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J].
Chen, Nanshan ;
Zhou, Min ;
Dong, Xuan ;
Qu, Jieming ;
Gong, Fengyun ;
Han, Yang ;
Qiu, Yang ;
Wang, Jingli ;
Liu, Ying ;
Wei, Yuan ;
Xia, Jia'an ;
Yu, Ting ;
Zhang, Xinxin ;
Zhang, Li .
LANCET, 2020, 395 (10223) :507-513
[4]   Antibody tests for identification of current and past infection with SARS-CoV-2 [J].
Deeks, Jonathan J. ;
Dinnes, Jacqueline ;
Takwoingil, Yemisi ;
Davenport, Clare ;
Spijker, Ren ;
Taylor-Phillips, Sian ;
Adrianol, Ada ;
Beesel, Sophie ;
Dretzkel, Janine ;
di Ruffanol, Lavinia Ferrante ;
Harris, Isobel M. ;
Price, Malcolm J. ;
Dittrich, Sabine ;
Emperador, Devy ;
Hooft, Lotty ;
Leeflang, Mariska M. G. ;
Van den Bruel, Ann .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (06)
[5]   Disparities in Age-specific Morbidity and Mortality From SARS-CoV-2 in China and the Republic of Korea [J].
Dudley, Joseph P. ;
Lee, Nam Taek .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) :863-865
[6]   Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya [J].
Etyang, Anthony O. ;
Lucinde, Ruth ;
Karanja, Henry ;
Kalu, Catherine ;
Mugo, Daisy ;
Nyagwange, James ;
Gitonga, John ;
Tuju, James ;
Wanjiku, Perpetual ;
Karani, Angela ;
Mutua, Shadrack ;
Maroko, Hosea ;
Nzomo, Eddy ;
Maitha, Eric ;
Kamuri, Evanson ;
Kaugiria, Thuranira ;
Weru, Justus ;
Ochola, Lucy B. ;
Kilimo, Nelson ;
Charo, Sande ;
Emukule, Namdala ;
Moracha, Wycliffe ;
Mukabi, David ;
Okuku, Rosemary ;
Ogutu, Monicah ;
Angujo, Barrack ;
Otiende, Mark ;
Bottomley, Christian ;
Otieno, Edward ;
Ndwiga, Leonard ;
Nyaguara, Amek ;
Voller, Shirine ;
Agoti, Charles N. ;
Nokes, David James ;
Ochola-Oyier, Lynette Isabella ;
Aman, Rashid ;
Amoth, Patrick ;
Mwangangi, Mercy ;
Kasera, Kadondi ;
Ng'ang'a, Wangari ;
Adetifa, Ifedayo M. O. ;
Kagucia, E. Wangeci ;
Gallagher, Katherine ;
Uyoga, Sophie ;
Tsofa, Benjamin ;
Barasa, Edwine ;
Bejon, Philip ;
Scott, J. Anthony G. ;
Agweyu, Ambrose ;
Warimwe, George M. .
CLINICAL INFECTIOUS DISEASES, 2022, 74 (02) :288-293
[7]   Review Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis [J].
Galanis, P. ;
Vraka, I. ;
Fragkou, D. ;
Bilali, A. ;
Kaitelidou, D. .
JOURNAL OF HOSPITAL INFECTION, 2021, 108 :120-134
[8]   Clinical Performance of SARS-CoV-2 Molecular Tests [J].
Green, Daniel A. ;
Zucker, Jason ;
Westblade, Lars F. ;
Whittier, Susan ;
Rennert, Hanna ;
Velu, Priya ;
Craney, Arryn ;
Cushing, Melissa ;
Liu, Dakai ;
Sobieszczyk, Magdalena E. ;
Boehme, Amelia K. ;
Sepulveda, Jorge L. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
[9]  
Galán MI, 2022, ENFERM INFEC MICR CL, V40, P302, DOI [10.1016/j.eimc.2020.11.015, 10.1016/j.eimce.2020.11.025]
[10]   Gender Differences in Patients With COVID-19: Focus on Severity and Mortality [J].
Jin, Jian-Min ;
Bai, Peng ;
He, Wei ;
Wu, Fei ;
Liu, Xiao-Fang ;
Han, De-Min ;
Liu, Shi ;
Yang, Jin-Kui .
FRONTIERS IN PUBLIC HEALTH, 2020, 8